Navigating Drug vs Device: IBAL’s FDA Pathway and the Power of Decentralized Science
Welcome back to Health Unlocked! In this episode, Jasen Petersen takes us deep into the world of medical devices, regulatory pathways, and the bold vision for the IBAL platform. Jasen Petersen breaks down the crucial differences between drugs and devices; why it matters for innovation, safety, and getting new therapies to patients faster. You'll hear firsthand about IBAL’s journey through regulatory approval in Mexico and the UAE, how previous groundwork helps set the stage for U.S. expansion...
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Health Unlocked: The Power of Salutogenesis
Navigating Medical Device Classifications and Funding Models for Next-Gen Therapeutics
Navigating Patent Strategy and Spinouts for Medical Innovation in Wound Care
When the Impossible Becomes Possible in Wound Healing
Advancing Wound Care: Conference Insights and Surprising Data from Innovative Gel Treatments
Get summaries like this every morning.
Free AI-powered recaps of Health Unlocked: The Power of Salutogenesis and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.